Tower Research Capital LLC (Trc) Passage Bio, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Passage Bio, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 54,479 shares of PASG stock, worth $22,336. This represents 0.0% of its overall portfolio holdings.
Number of Shares
54,479
Previous 5,030
983.08%
Holding current value
$22,336
Previous $3,000
933.33%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding PASG
# of Institutions
47Shares Held
37.7MCall Options Held
10.5KPut Options Held
0-
Lynx1 Capital Management LP San Juan, PR9.26MShares$3.8 Million2.05% of portfolio
-
Orbimed Advisors LLC San Diego, CA7.4MShares$3.04 Million0.11% of portfolio
-
Vestal Point Capital, LP New York, NY6.1MShares$2.5 Million0.21% of portfolio
-
New Leaf Venture Partners, L.L.C. New York, NY2.5MShares$1.02 Million1.92% of portfolio
-
Erste Asset Management Gmb H Vienna, C42.46MShares$1.01 Million0.02% of portfolio
About Passage BIO, Inc.
- Ticker PASG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,463,200
- Market Cap $22.3M
- Description
- Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...